Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sousuke Kubo

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
BMJ Case Reports|May 8, 2024
Large-vessel vasculitis possibly induced by BRAF and MEK inhibitors for BRAF V600E positive lung adenocarcinomaKento Ichikawa, Shigeru Ohno, Sousuke Kubo, et al.
Respirology Case Reports|August 30, 2019
Computed tomography imaging-based observation of the aggressive growth of angiosarcoma: a case studySousuke Kubo, Nobuaki Kobayashi, Ayami Kaneko, et al.
Thoracic Cancer|February 19, 2020
Class A CpG oligodeoxynucleotide inhibits IFN-γ-induced signaling and apoptosis in lung cancerShuhei Teranishi, Nobuaki Kobayashi, Seigo Katakura, et al.
Journal of Cancer Research and Clinical Oncology|October 25, 2023
Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancerSousuke Kubo, Nobuaki Kobayashi, Hiromi Matsumoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 13, 2023
Influence of age, IGRA results, and inflammatory markers on mortality in hospitalized tuberculosis patientsNobuaki Kobayashi, Katsushi Tanaka, Suguru Muraoka, et al.
Acute Medicine & Surgery|April 22, 2020
Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in JapanHayato Taniguchi, Fumihiro Ogawa, Hiroshi Honzawa, et al.
Scientific Reports|March 30, 2023
Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in JapanHiromi Matsumoto, Nobuaki Kobayashi, Satoru Shinoda, et al.
Anticancer Research|July 5, 2020
Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint InhibitorSousuke Kubo, Nobuaki Kobayashi, Kohei Somekawa, et al.
Tuberculosis (Edinburgh, Scotland)|September 21, 2020
Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in JapanSeigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, et al.
Translational Lung Cancer Research|August 13, 2025
MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancerAyami Kaneko, Nobuaki Kobayashi, Sousuke Kubo, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
BMJ Case Reports|May 8, 2024
Large-vessel vasculitis possibly induced by BRAF and MEK inhibitors for BRAF V600E positive lung adenocarcinomaKento Ichikawa, Shigeru Ohno, Sousuke Kubo, et al.
Respirology Case Reports|August 30, 2019
Computed tomography imaging-based observation of the aggressive growth of angiosarcoma: a case studySousuke Kubo, Nobuaki Kobayashi, Ayami Kaneko, et al.
Thoracic Cancer|February 19, 2020
Class A CpG oligodeoxynucleotide inhibits IFN-γ-induced signaling and apoptosis in lung cancerShuhei Teranishi, Nobuaki Kobayashi, Seigo Katakura, et al.
Journal of Cancer Research and Clinical Oncology|October 25, 2023
Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancerSousuke Kubo, Nobuaki Kobayashi, Hiromi Matsumoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 13, 2023
Influence of age, IGRA results, and inflammatory markers on mortality in hospitalized tuberculosis patientsNobuaki Kobayashi, Katsushi Tanaka, Suguru Muraoka, et al.
Acute Medicine & Surgery|April 22, 2020
Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in JapanHayato Taniguchi, Fumihiro Ogawa, Hiroshi Honzawa, et al.
Scientific Reports|March 30, 2023
Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in JapanHiromi Matsumoto, Nobuaki Kobayashi, Satoru Shinoda, et al.
Anticancer Research|July 5, 2020
Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint InhibitorSousuke Kubo, Nobuaki Kobayashi, Kohei Somekawa, et al.
Tuberculosis (Edinburgh, Scotland)|September 21, 2020
Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in JapanSeigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, et al.
Translational Lung Cancer Research|August 13, 2025
MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancerAyami Kaneko, Nobuaki Kobayashi, Sousuke Kubo, et al.
Pageof 3